News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Conference News CRT 2020 Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR L.A. McKeown February 24, 2020
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2018 Shelley Wood October 31, 2018
News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Daily News Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk Michael O'Riordan June 20, 2018
News Conference News CRT 2018 Ticagrelor: Better Platelet Blockade Post-TAVR? Michael O'Riordan March 07, 2018
News Conference News ESC 2017 Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death Yael L. Maxwell September 01, 2017
News Conference News ACC 2017 Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery Michael O'Riordan March 19, 2017
News Daily News Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban Michael O'Riordan January 03, 2017